These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2426566)

  • 21. Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer.
    Ucar E; Semerci E; Ustun H; Yetim T; Huzmeli C; Gullu M
    Adv Ther; 2008 Oct; 25(10):1075-84. PubMed ID: 18821070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative detection of carcinoembryonic antigen messenger RNA in the peritoneal cavity of gastric cancer patients by real-time quantitative reverse transcription polymerase chain reaction.
    Ueno H; Yoshida K; Hirai T; Kono F; Kambe M; Toge T
    Anticancer Res; 2003; 23(2C):1701-8. PubMed ID: 12820444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sharp decline in plasma CEA and reduction of liver metastasis after UFT administration in a patient with recurrent gastric cancer].
    Okuda T; Onda M; Tokunaga A; Teramoto T; Fujita I; Mizutani T; Kiyama T; Nishi K; Okazaki S; Kyono S
    Gan To Kagaku Ryoho; 1992 Oct; 19(12):2099-102. PubMed ID: 1417017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A combination immunochemotherapy of 5-fluorouracil, cisplatin, leucovorin, and OK-432 for advanced and recurrent gastric carcinoma.
    Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Noguchi Y
    Hepatogastroenterology; 2003; 50(54):2259-63. PubMed ID: 14696512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Metastasis rates of lymph nodes and distribution in advanced gastric cancer and its clinical significance].
    Nzengue JC; Zhan WH; Wang JP; Dong WG; Lan P; He YL; Chen ZX; Cai SR
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):506-9. PubMed ID: 17143796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of lymph node metastases and expression of matrix metalloproteinase-7 in patients with gastric cancer.
    Ajisaka H; Yonemura Y; Miwa K
    Hepatogastroenterology; 2004; 51(57):900-5. PubMed ID: 15143943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Correlation between expression of RB protein and prognosis of gastric cancer].
    Ogawa M; Maeda K; Chung YS; Onoda N; Kato Y; Nakata B; Sowa M
    Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():148-50. PubMed ID: 8678558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metachronous hepatic metastases from gastric carcinoma: a multicentric survey.
    Tiberio GA; Coniglio A; Marchet A; Marrelli D; Giacopuzzi S; Baiocchi L; Roviello F; de Manzoni G; Nitti D; Giulini SM
    Eur J Surg Oncol; 2009 May; 35(5):486-91. PubMed ID: 19171450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical significance of serum CA 125 values in patients with gastric cancers--especially correlation with peritonitis carcinomatosa].
    Takahashi Y; Suga T; Mai M
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):975-9. PubMed ID: 1626954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical significance of molecular biological detection of micrometastases in gastric carcinoma].
    Tsujitani S; Kaibara N
    Nihon Geka Gakkai Zasshi; 2001 Oct; 102(10):741-4. PubMed ID: 11680998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence.
    Sanchez-Cespedes M; Esteller M; Hibi K; Cope FO; Westra WH; Piantadosi S; Herman JG; Jen J; Sidransky D
    Clin Cancer Res; 1999 Sep; 5(9):2450-4. PubMed ID: 10499618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors in patients with advanced gastric cancer treated by noncurative resection: a multivariate analysis.
    Tsujitani S; Oka S; Suzuki K; Saito H; Kondo A; Ikeguchi M; Maeta M; Kaibara N
    Hepatogastroenterology; 2001; 48(41):1504-8. PubMed ID: 11677996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mechanism by which peritoneal disseminated metastasis develops in gastric cancer].
    Imada T; Matsumoto A
    Nihon Geka Gakkai Zasshi; 1986 Jun; 87(6):593-603. PubMed ID: 3736535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors influencing growth rate of recurrent stomach cancers as determined by analysis of serum carcinoembryonic antigen.
    Takahashi Y; Mai M; Kusama S
    Cancer; 1995 Mar; 75(6 Suppl):1497-502. PubMed ID: 7889481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Utility of dopa decarboxylase as a novel marker for the detection of peritoneal micro-metastases of gastric cancer with realtime RT-PCR].
    Sakakura C; Takemura M; Miyagawa K; Fukuda K; Shimomura K; Kin S; Nakase Y; Kuriu Y; Nakashima S; Yoshikawa T; Ueda Y; Fujiyama J; Sonoyama T; Okazaki Y; Hayashizaki Y; Hagiwara A; Yamagishi H
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1906-8. PubMed ID: 15553755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pertinent risk factors and gastric carcinoma with synchronous peritoneal dissemination or liver metastasis.
    Maehara Y; Moriguchi S; Kakeji Y; Kohnoe S; Korenaga D; Haraguchi M; Sugimachi K
    Surgery; 1991 Nov; 110(5):820-3. PubMed ID: 1948650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive factors of early recurrent death after a curative resection of gastric cancer.
    Mikami K; Maekawa T; Shinohara T; Hoshino S; Yamauchi Y; Noritomi T; Yamashita Y
    Int Surg; 2009; 94(2):144-8. PubMed ID: 20108618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors in early gastric cancer.
    Kunisaki C; Shimada H; Takahashi M; Ookubo K; Moriwaki Y; Akiyama H; Nomura M
    Hepatogastroenterology; 2001; 48(37):294-8. PubMed ID: 11268989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of hepatic resection for metastatic gastric cancer.
    Roh HR; Suh KS; Lee HJ; Yang HK; Choe KJ; Lee KU
    Am Surg; 2005 Feb; 71(2):95-9. PubMed ID: 16022005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of RegIV in peritoneal dissemination of gastric cancer and its potential as A novel marker for the detection of peritoneal micrometastasis.
    Miyagawa K; Sakakura C; Nakashima S; Yoshikawa T; Fukuda K; Kin S; Nakase Y; Shimomura K; Oue N; Yasui W; Hayasizaki H; Okazaki Y; Yamagishi H; Hagiwara A; Otsuji E
    Anticancer Res; 2008; 28(2B):1169-79. PubMed ID: 18505053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.